Strand Therapeutics
Latest round
- Series B
Last raised
- Aug 2025
Total raised
- $256M
Investors
- 17
About Strand Therapeutics
Founded in 2017 and headquartered in Massachusetts, US, Strand Therapeutics Inc. specializes in developing programmable, long-acting mRNA therapeutics, focusing on innovative treatments for cancer and other serious diseases through advanced biotechnology. focuses on creating mRNA-based medicines. In August 2025, Strand Therapeutics Inc.
Who invested in Strand Therapeutics
17 investors across 4 rounds
See all investors in Strand Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Strand Therapeutics
Who invested in Strand Therapeutics?
Strand Therapeutics has 17 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Strand Therapeutics raised?
Strand Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Strand Therapeutics last raise money?
Strand Therapeutics's most recent round on record is a Series B, in Aug 2025.
What does Strand Therapeutics do?
Founded in 2017 and headquartered in Massachusetts, US, Strand Therapeutics Inc.
Where is Strand Therapeutics headquartered?
Strand Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Strand Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Strand Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Strand Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.